pamidronate has been researched along with Mastocytosis, Systemic in 3 studies
Mastocytosis, Systemic: A group of disorders caused by the abnormal proliferation of MAST CELLS in a variety of extracutaneous tissues including bone marrow, liver, spleen, lymph nodes, and gastrointestinal tract. Systemic mastocytosis is commonly seen in adults. These diseases are categorized on the basis of clinical features, pathologic findings, and prognosis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Systemic mastocytosis is characterised by proliferation of mast cells and infiltration of organs." | 1.33 | Involvement of the jaw bones in systemic mastocytosis. ( Castling, B; Myers, B; Smith, AT, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Myers, B | 2 |
| Castling, B | 1 |
| Smith, AT | 1 |
| Laroche, M | 1 |
| Bret, J | 1 |
| Brouchet, A | 1 |
| Mazières, B | 1 |
3 other studies available for pamidronate and Mastocytosis, Systemic
| Article | Year |
|---|---|
Comment on systemic mastocytosis study.
Topics: Adult; Diphosphonates; Humans; Interferon-alpha; Male; Mastocytosis, Systemic; Middle Aged; Pain; Pa | 2003 |
Involvement of the jaw bones in systemic mastocytosis.
Topics: Adult; Bone Density Conservation Agents; Diphosphonates; Histamine H1 Antagonists; Humans; Jaw Neopl | 2006 |
Clinical and densitometric efficacy of the association of interferon alpha and pamidronate in the treatment of osteoporosis in patients with systemic mastocytosis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Bone Density; Bone Marrow Cells; Bone Remodeling; Diphosphona | 2007 |